An Efficacy and Safety Study of Gevokizumab in Treating Active Ulcers of Pyoderma Gangrenosum
NCT02326740 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 9
Last updated 2016-04-27
Summary
The study will evaluate the efficacy and safety of gevokizumab in treating active ulcers of pyoderma gangrenosum (PG).
Conditions
- Pyoderma Gangrenosum
Interventions
- DRUG
-
gevokizumab
- DRUG
- DRUG
-
gevokizumab open-label
Sponsors & Collaborators
-
XOMA (US) LLC
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-12-31
- Primary Completion
- 2016-03-31
- Completion
- 2016-03-31
Countries
- United States
- Australia
- Canada
Study Locations
More Related Trials
-
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
NCT01594762 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness of dermaPACE™ Device and Standard Treatment Compared to Standard Treatment Alone for Diabetic Foot Ulcers
NCT00536744 ·Status: COMPLETED ·Phase: PHASE3
-
Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers
NCT02119754 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Intramuscular PDA-002 in Subjects Who Have Diabetic Foot Ulcer With and Without Peripheral Arterial Disease
NCT02264288 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy Study for Geko Device in VLU Patients (Canada)
NCT05057793 ·Status: TERMINATED ·Phase: NA
-
Diabetic Foot Ulcer (DFU) Rapid Pathogen Identification
NCT06569238 ·Status: COMPLETED ·Phase: NA
-
IDEAL: Efficacy of Porcine Placental Extracellular Matrix Augmented Plus Standard of Care (SOC) Versus SOC Alone for the Management of Diabetic Foot Ulcers
NCT06616844 ·Status: RECRUITING ·Phase: NA
-
Evaluating Safety and Biological Effect on Wound Healing of ILP100-Topical in Subjects With Diabetic Foot Ulcers
NCT05608187 ·Status: TERMINATED ·Phase: PHASE2
-
Study of AMG0001 to Improve Ulcer Healing and Perfusion in Subjects With Peripheral Ischemic Ulcers
NCT04267640 ·Status: UNKNOWN ·Phase: PHASE2
-
Prostacyclin (PGI2) Pathway to Enhance Wound Healing in Diabetic Foot Ulcers
NCT05099367 ·Status: RECRUITING ·Phase: NA
-
Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers
NCT02091596 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Granexin Gel in the Treatment of Diabetic Foot Ulcer
NCT02667327 ·Status: TERMINATED ·Phase: PHASE3
-
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
NCT01590758 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 2 Exploratory Pharmacodynamic Study of HP802-247 in Venous Leg Ulcers
NCT02154087 ·Status: TERMINATED ·Phase: PHASE2
-
Safety and Efficacy Study of Neovasculgen (Pl-VEGF165) Gene Therapy in Patients With Diabetic Foot
NCT02538705 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy Study of MRE0094 to Treat Chronic, Neuropathic, Diabetic Foot Ulcers
NCT00312364 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Investigate the Safety and Clinical Effect of Nexagon® to Treat Persistent Epithelial Defects
NCT00821561 ·Status: WITHDRAWN ·Phase: PHASE2
-
Diabetic Foot Ulcers Microbiome and Pathogen Identification
NCT05556954 ·Status: COMPLETED
-
A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Venous Leg Ulcers
NCT01138436 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Evaluation of the Intralesional Recombinant Human Epidermal Growth Factor (rhEGF) in Subjects With Diabetic Foot Ulcer.
NCT02554851 ·Status: UNKNOWN ·Phase: PHASE3
-
NOX1416 in Treatment of Chronic Non-Healing Diabetic Foot Ulcers
NCT06402565 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
A Randomized Controlled Phase II Trial of STIMULAN VG vs Standard of Care (SoC) for the Treatment of Osteomyelitis Associated With Stage IV Pressure Ulcers.
NCT06283979 ·Status: RECRUITING ·Phase: PHASE2
-
Hyperbaric Oxygen Therapy for Pyoderma Gangrenosum
NCT05343754 ·Status: TERMINATED ·Phase: PHASE3
-
Study of a Topical Gentamicin-Collagen Sponge Along With Systemic Antibiotic in Infected Diabetic Foot Ulcers
NCT02427802 ·Status: COMPLETED ·Phase: PHASE3
-
Developing Strategies for Effective Debridement in Patients for Venous Leg Ulcers
NCT03796793 ·Status: COMPLETED ·Phase: NA